FORMA Therapeutics today announced the appointment of Paolo Paoletti, M.D., former President, GlaxoSmithKline Oncology, to the company's Board of Directors. In addition to serving as a director, Dr. Paoletti will also lead FORMA's Research & Development Committee as its chairperson; in this capacity, his strategic clinical and research insights will be applied to FORMA's target family drug discovery paradigm.